Abstract
A case of colchicine-induced rhabdomyolysis is reported. A 79-year-old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of fatigue, myalgia, and leg weakness, shortly after starting treatment with colchicine. Investigation confirmed the diagnosis of rhabdomyolysis, and discontinuation of colchicine resulted in resolution of clinical and biochemical features of rhabdomylysis. Colchicine-induced rhabdomyolysis is a rare complication, and the postulated mechanisms and risk factors for this severe complication are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Insel PA (1996) Analgesic–antipyretic and anti inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, Molineff PB et al (eds) The pharmacological basis of therapeutics. Mcgraw-Hill, New York, pp 647–649
Wilbur F, Makowsky M (2004) Colchicine myotoxicity: case reports and literature review. Pharmacotherapy 24:1784–1792
Dawson TM, Starkebaum G (1997) Colchicine induced rhabdomyolysis. J Rheumatol 24:2045–2046
Del Favero A (1981) Anti-inflammatory analgesics and drugs used in rheumatism and gout. In: Dukes MNG (ed) Side effects of drugs. Excerpta Medica, New York, p 109
Chattopaahyay I, Sherry HGM, Routledge PA, Jeffery J (2001) Colchicine induced rhabdomyolysis. Postgrad Med J 77:191–192
Wallace SL, Singer JZ, Duncan GJ, Wigley FM, Kuncl RW (1991) Renal function predicts colchicines toxicity: guidelines for the prophylactic use of colchicines in gout. J Rheumatol 18:264–269
Younger DS, Mayer SA, Weimer LH, Alderson LM, Seplowitz AH, Lovelace RE (1991) Colchicine myopathy and neuropathy. Neurology 41:943
Rieger EH, Halasz NA, Wahlstrom LM (1990) Colchicine neuromyopathy after renal transplantation. Transplantation 49:1196–1198
Kontos HA (1962) Myopathy associated with chronic colchicines toxicity. N Eng J Med 266:38–39
Kuncl RW, Ducan G, Watson D et al (1987) Colchicine myopathy and neuropathy. N Eng J Med 316:1562–1568
Rriggs JE, Schocher SS Jr, Gutmann L, Crosby TW, DiBartolomeo AG (1986) Chronic human colchicine neuropathy and myopathy. Arch Neurol 43:521–523
Adler Y, Finkelstein Y, Guindo J et al (1998) Colchicine treatment for recurrent pericarditis: a decade of experience. Circulation 97:2183–2185
Sullivan TP, King LE Jr, Boyd AS (1998) Colchine in dermatology. J Am Acad Dermatol 39:993–999
Lange U, Schumann C, Schmidt KL (2001) Current aspects of colchicines therapy: classical indications and new therapeutic uses. Eur J Med Res 6:150–160
Naidus RM, Rodvein R, Mielke CH Jr (1997) Colchicine toxicity: a multisystem disease. Arch Intern Med 137:394–396
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Altman, A., Szyper-Kravitz, M. & Shoenfeld, Y. Colchicine-induced rhabdomyolysis. Clin Rheumatol 26, 2197–2199 (2007). https://doi.org/10.1007/s10067-007-0682-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0682-2